Obituaries

Philip D'Arcy Hart

BMJ 2006; 333 doi: http://dx.doi.org/10.1136/bmj.333.7565.449 (Published 24 August 2006) Cite this as: BMJ 2006;333:449

Medical researcher who pioneered the controlled clinical trial as a gold standard and who demonstrated the efficacy of streptomycin as a treatment for tuberculosis

In a long career—he lived to 106 and worked until he was 102—Philip D'Arcy Hart showed that pneumoconiosis was an industrial disease for which sufferers should receive compensation. In a landmark controlled clinical trial with Sir Austin Bradford Hill, Hart showed that streptomycin, then newly discovered, cured tuberculosis. In 1965 he was made a CBE for this work. He did other major epidemiology, retired at 65, and spent the next 37 years making fundamental advances on the pathogenesis of tubercle bacilli.


Embedded Image

Credit: NICK SINCLAIR

Philip Montagu D'Arcy Hart was born in London in 1900 to a wealthy, cultivated, and philanthropic family. His father trained as a barrister but abandoned the bar to become a successful painter; his mother was the daughter of Samuel Montagu, first Baron Swaythling, Liberal MP and founder of a merchant bank. Philip was educated at Clifton College, …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe